University of Toronto - Department of Nutritional Sciences
Toronto, Ontario, M5S 3E2, Canada
NCT Number: NCT01255085
It is hypothesized that yellow pea protein and fiber will reduce short-term food intake, subjective appetite and glycemic response.
Looking for future studies?
Notify Me20 year–29 year
Male
Interventional
Not applicable
Toronto, Ontario, M5S 3E2, Canada
A within-subject, randomized study was conducted. Each subject returned 5 times, 1 week apart, and received 1 of the 5 treatments per week. The 5 treatments were tomato soup with 10 or 20 g of isolated yellow pea fibre or protein, or a control soup with no added pea fractions. Food intake was measured at an ad libitum pizza meal served 30 minutes after treatment. Satiety and blood glucose (via finger prick) were measured throughout the treatment period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Served in a tomato soup
Served in a tomato soup
Served in a tomato soup
Time frame: at 30 minutes after treatment
Energy intake at an ad libitum pizza meal
Time frame: 0-170 minutes post treatment
Blood Glucose every 15-30 minutes via finger prick
Time frame: 0-170 minutes post treatment
Subjective Appetite measured every 15-30 minutes via Visual Analog Scale (VAS)
University of Toronto
Other
The Effect of Yellow Pea Protein and Fiber on Short Term Food Intake, Subjective Appetite and Glycemic Response in Healthy Young Males
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01242059
Body Weight, Diabetes Mellitus
Toronto, Ontario, Canada
View Trial DetailsNCT06461273
Behavior, Body Weight
Newark, New Jersey, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT01283113
Body Weight, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details